Read More Analyst Ratings News Price Target Reiteration Tech Trading Ideas Arm Holdings Analysts Stay Bullish With Licensing Gains Overshadowing Royalty Concerns By Anusuya Lahiri November 9, 2:49 PM BMO Capital analyst Ambrish Srivastava reiterated a Market Perform rating on Arm Holdings Plc (NASDAQ: ARM) with a ARM
Read More Analyst Ratings News Price Target Wells Fargo Maintains Overweight on Brookfield Renewable, Lowers Price Target to $37 By Benzinga Newsdesk November 7, 11:24 AM Wells Fargo analyst Jonathan Reeder maintains Brookfield Renewable (NYSE:BEPC) with a Overweight and lowers the price target from $41 to $37. BEPC
Read More Analyst Color Analyst Ratings Biotech General Health Care Movers News Penny Stocks Trading Ideas Upgrades Verrica’s Ycanth Unlikely to Face Near-Term Competition, Analyst Upgrades Stock On FDA Approval By Vandana Singh July 25, 1:03 PM Monday, the FDA approved Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) Ycanth (cantharidin) topical solution for molluscum contagiosum (molluscum) in adult and pediatric patients NOVN
Read More News Tech The Other Apple CEO Steve Wozniak Is Thankful For (Hint: It’s Not Steve Jobs) By Ananya Gairola March 9, 4:06 AM Apple Inc. (NASDAQ:AAPL) co-founder Steve Wozniak took to Twitter to “thank” a former CEO of the company —… AAPL